Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial

被引：0
|
作者：
Nobuya Inagaki
Wenying Yang
Hirotaka Watada
Linong Ji
Sven Schnaidt
Egon Pfarr
Tomoo Okamura
Odd Erik Johansen
Jyothis T. George
Maximilian von Eynatten
Julio Rosenstock
Vlado Perkovic
Christoph Wanner
Mark E. Cooper
John H. Alexander
Issei Komuro
Masaomi Nangaku
机构：
[1] Kyoto University,Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine
[2] China-Japan Friendship Hospital,Department of Endocrinology
[3] Juntendo University Graduate School of Medicine,Department of Metabolism and Endocrinology
[4] Peking University People’s Hospital,Department of Endocrinology and Metabolism
[5] Boehringer Ingelheim Pharma GmbH & Co KG,Dallas Diabetes Research Center at Medical City
[6] Boehringer Ingelheim Pharma GmbH & Co KG,George Institute for Global Health, Faculty of Medicine
[7] Nippon Boehringer Ingelheim Co.,Division of Nephrology, Department of Medicine
[8] Ltd,Department of Diabetes, Central Clinical School
[9] Boehringer Ingelheim Norway KS,Department of Cardiovascular Medicine
[10] Boehringer Ingelheim International GmbH,Division of Nephrology and Endocrinology
[11] University of Texas Southwestern Medical Center,undefined
[12] University of New South Wales,undefined
[13] Würzburg University Clinic,undefined
[14] Monash University,undefined
[15] Duke Clinical Research Institute,undefined
[16] Duke Health,undefined
[17] University of Tokyo Hospital,undefined
[18] The University of Tokyo Graduate School of Medicine,undefined
来源：
Diabetology International | 2020年 / 11卷
关键词：
Diabetes mellitus, type 2; Cardiovascular diseases; Renal insufficiency, chronic; Prescription drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 141
页数：12
相关论文
共 50 条
  • [21] Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
    Green, Jennifer B.
    Bethel, M. Angelyn
    Paul, Sanjoy K.
    Ring, Arne
    Kaufman, Keith D.
    Shapiro, Deborah R.
    Califf, Robert M.
    Holman, Rury R.
    AMERICAN HEART JOURNAL, 2013, 166 (06) : 983 - U83
  • [22] Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
    Lautsch, Dominik
    Wang, Tongtong
    Yang, Lingfeng
    Rajpathak, Swapnil N.
    DIABETES THERAPY, 2019, 10 (06) : 2131 - 2137
  • [23] Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
    Dominik Lautsch
    Tongtong Wang
    Lingfeng Yang
    Swapnil N. Rajpathak
    Diabetes Therapy, 2019, 10 : 2131 - 2137
  • [24] Linagliptin in the Management of Type 2 Diabetes Mellitus After Kidney Transplant
    Attallah, Nizar
    Yassine, Lina
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (07) : 2234 - 2237
  • [25] Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial (vol 14,pg 226, 2021)
    Wanner, Christoph
    Cooper, Mark E.
    Johansen, Odd Erik
    Toto, Robert
    Rosenstock, Julio
    McGuire, Darren K.
    Kahn, Steven E.
    Pfarr, Egon
    Schnaidt, Sven
    von Eynatten, Maximilian
    George, Jyothis T.
    Gollop, Nicholas D.
    Marx, Nikolaus
    Alexander, John H.
    Zinman, Bernard
    Perkovic, Vlado
    CLINICAL KIDNEY JOURNAL, 2021, 14 (09) : 2136 - 2136
  • [26] TYPE 2 DIABETES, CHRONIC KIDNEY DISEASE, AND MORTALITY IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Rein, Philipp
    Muendlein, Axel
    Drexel, Heinz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1841 - 1841
  • [27] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Mader, A.
    Larcher, B.
    Muendlein, A.
    Drexel, H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 : 156 - 156
  • [28] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Schuler, Alexandra
    Ebner, Karl-Martin
    Rein, Philipp
    Schwerzler, Peter
    Mader, Arthur
    Muendlein, Axel
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S128 - S128
  • [29] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Schuler, A.
    Schwerzler, P.
    Mader, A.
    Rein, P.
    Muendlein, A.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 324 - 324
  • [30] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Ebner, Karl-Martin
    Schwerzler, Peter
    Mader, Arthur
    Heinzle, Christine
    Muendlein, Axel
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 170 - 170
12345